Trial Outcomes & Findings for TENS Trial to Prevent Neuropathic Pain in SCI (NCT NCT03267810)

NCT ID: NCT03267810

Last Updated: 2023-07-14

Results Overview

as defined by a score of ≥2 on the Spinal Cord Injury Pain Inventory (SCIPI), a self-report scale of symptoms. SCIPI has a total score ranging from 0 to 4 with scores of \>=2 screening positive for Neuropathic Pain in people with spinal cord injury

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

31 participants

Primary outcome timeframe

12 months

Results posted on

2023-07-14

Participant Flow

Participant milestones

Participant milestones
Measure
Active TENS
Participants are given 30 minutes of TENS therapy twice a week for 8 weeks. TENS: TENS 7000 - : TENS will apply low-level electrical current via four pads, two applied paraspinally at the level of spinal cord injury, and two applied on the ventral side of the body within the dermatome corresponding to the level of injury . 15 minutes of high frequency followed by 15 minutes of low frequency will be applied at each session
Sham TENS
Electrodes are placed on participants for 30 minutes twice a week for 8 weeks without TENS stimulation. Sham TENS: Inactive electrodes - for two 15 minute trials, neither high nor low frequency.
Overall Study
STARTED
13
13
Overall Study
COMPLETED
10
12
Overall Study
NOT COMPLETED
3
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

TENS Trial to Prevent Neuropathic Pain in SCI

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active TENS
n=13 Participants
Participants are given 30 minutes of TENS therapy twice a week for 8 weeks. TENS: TENS 7000 - : TENS applies low-level electrical current via four pads, 2 pads affixed paraspinally, at the level of the spinal cord injury, and 2 affixed on the ventral side to areas within the dermatome corresponding to the level of injury. 15 minutes of high frequency followed by 15 minutes of low frequency will be applied at each session
Sham TENS
n=13 Participants
Electrodes are placed on participants for 30 minutes twice a week for 8 weeks without TENS stimulation. Sham TENS: Inactive electrodes - for two 15 minute trials, neither high nor low frequency.
Total
n=26 Participants
Total of all reporting groups
Age, Continuous
33.38 years
STANDARD_DEVIATION 13.27 • n=99 Participants
38.15 years
STANDARD_DEVIATION 17.13 • n=107 Participants
35.77 years
STANDARD_DEVIATION 15.21 • n=206 Participants
Sex: Female, Male
Female
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
Sex: Female, Male
Male
11 Participants
n=99 Participants
11 Participants
n=107 Participants
22 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
8 Participants
n=99 Participants
5 Participants
n=107 Participants
13 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
5 Participants
n=99 Participants
8 Participants
n=107 Participants
13 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
4 Participants
n=99 Participants
4 Participants
n=107 Participants
8 Participants
n=206 Participants
Race (NIH/OMB)
White
9 Participants
n=99 Participants
9 Participants
n=107 Participants
18 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants

PRIMARY outcome

Timeframe: 12 months

Population: Analyses were performed were on all participants enrolled in each arm using the "last observation carried forward" process.

as defined by a score of ≥2 on the Spinal Cord Injury Pain Inventory (SCIPI), a self-report scale of symptoms. SCIPI has a total score ranging from 0 to 4 with scores of \>=2 screening positive for Neuropathic Pain in people with spinal cord injury

Outcome measures

Outcome measures
Measure
Sham TENS
n=13 Participants
Electrodes are placed on participants for 30 minutes twice a week for 8 weeks without TENS stimulation. Sham TENS: Inactive electrodes - for two 15 minute trials, neither high nor low frequency.
Active TENS
n=13 Participants
Participants are given 30 minutes of TENS therapy twice a week for 8 weeks. TENS: TENS 7000 - : TENS will apply low-level electrical current via four pads affixed to the lower back area. 15 minutes of high frequency followed by 15 minutes of low frequency will be applied at each session
The Percentage of Subjects Who Develop Chronic Neuropathic Pain.
46 percentage of participants
31 percentage of participants

PRIMARY outcome

Timeframe: 12 months

Population: Analyses were performed were on all participants enrolled in each arm using the "last observation carried forward" process.

NPSI has a total score ranging from 0 to 100 with the higher score indicating more severe symptoms of neuropathic pain

Outcome measures

Outcome measures
Measure
Sham TENS
n=13 Participants
Electrodes are placed on participants for 30 minutes twice a week for 8 weeks without TENS stimulation. Sham TENS: Inactive electrodes - for two 15 minute trials, neither high nor low frequency.
Active TENS
n=13 Participants
Participants are given 30 minutes of TENS therapy twice a week for 8 weeks. TENS: TENS 7000 - : TENS will apply low-level electrical current via four pads affixed to the lower back area. 15 minutes of high frequency followed by 15 minutes of low frequency will be applied at each session
Neuropathic Pain Symptom Inventory (NPSI) Scores
14 score on a scale
Interval 0.0 to 23.0
23 score on a scale
Interval 0.0 to 33.0

SECONDARY outcome

Timeframe: 12 months

Population: Analyses were performed were on all participants enrolled in each arm using the "last observation carried forward" process.

Number of participants reporting adverse events related to study treatment as evaluated by physician

Outcome measures

Outcome measures
Measure
Sham TENS
n=13 Participants
Electrodes are placed on participants for 30 minutes twice a week for 8 weeks without TENS stimulation. Sham TENS: Inactive electrodes - for two 15 minute trials, neither high nor low frequency.
Active TENS
n=13 Participants
Participants are given 30 minutes of TENS therapy twice a week for 8 weeks. TENS: TENS 7000 - : TENS will apply low-level electrical current via four pads affixed to the lower back area. 15 minutes of high frequency followed by 15 minutes of low frequency will be applied at each session
Number of Participants With Adverse Events
2 Participants
1 Participants

SECONDARY outcome

Timeframe: 12 months

Population: Analyses were performed were on all participants enrolled in each arm using the "last observation carried forward" process.

Self-report composite rating scale of interference of pain with activities, mood, and sleep. This scale has a total score ranging from 0 to 30, with a higher score indicating greater pain interference.

Outcome measures

Outcome measures
Measure
Sham TENS
n=13 Participants
Electrodes are placed on participants for 30 minutes twice a week for 8 weeks without TENS stimulation. Sham TENS: Inactive electrodes - for two 15 minute trials, neither high nor low frequency.
Active TENS
n=13 Participants
Participants are given 30 minutes of TENS therapy twice a week for 8 weeks. TENS: TENS 7000 - : TENS will apply low-level electrical current via four pads affixed to the lower back area. 15 minutes of high frequency followed by 15 minutes of low frequency will be applied at each session
Pain Interference With Function
1 score on a scale
Interval 0.0 to 10.0
0 score on a scale
Interval 0.0 to 11.0

SECONDARY outcome

Timeframe: 12 months

Population: Analyses were performed were on all participants enrolled in each arm using the "last observation carried forward" process.

Patient Health Questionnaire - 9 (PHQ-9) has a total score ranging from 0 to 27, with a higher score indicating greater depressive symptoms

Outcome measures

Outcome measures
Measure
Sham TENS
n=13 Participants
Electrodes are placed on participants for 30 minutes twice a week for 8 weeks without TENS stimulation. Sham TENS: Inactive electrodes - for two 15 minute trials, neither high nor low frequency.
Active TENS
n=13 Participants
Participants are given 30 minutes of TENS therapy twice a week for 8 weeks. TENS: TENS 7000 - : TENS will apply low-level electrical current via four pads affixed to the lower back area. 15 minutes of high frequency followed by 15 minutes of low frequency will be applied at each session
Depressive Symptoms
1 score on a scale
Interval 1.0 to 5.0
4 score on a scale
Interval 3.0 to 8.0

Adverse Events

Active TENS

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Sham TENS

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Active TENS
n=13 participants at risk
Participants are given 30 minutes of TENS therapy twice a week for 8 weeks. TENS: TENS 7000 - : TENS applies low-level electrical current via four pads, 2 pads affixed paraspinally, at the level of the spinal cord injury, and 2 affixed on the ventral side to areas within the dermatome corresponding to the level of injury. 15 minutes of high frequency followed by 15 minutes of low frequency will be applied at each session
Sham TENS
n=13 participants at risk
Electrodes are placed on participants for 30 minutes twice a week for 8 weeks without TENS stimulation. Sham TENS: Inactive electrodes - for two 15 minute trials, neither high nor low frequency.
General disorders
episode of severe nerve pain
0.00%
0/13 • 12 months
7.7%
1/13 • 12 months
Injury, poisoning and procedural complications
broken foot
7.7%
1/13 • 12 months
0.00%
0/13 • 12 months
Infections and infestations
Urinary tract infection
0.00%
0/13 • 12 months
7.7%
1/13 • 12 months
General disorders
increased pain
7.7%
1/13 • 12 months
7.7%
1/13 • 12 months
General disorders
prolonged dysesthesia
15.4%
2/13 • 12 months
7.7%
1/13 • 12 months

Additional Information

Elizabeth Felix

University of Miami

Phone: 305-243-4497

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place